“Effects of inhibition of lymphangiogenesis by the vascular endothelial growth factor receptor 3 (VEGFR-3) inhibitor, MAZ51 on full thickness wounds in mice” (2021) Veins and Lymphatics, 10(1). doi:10.4081/vl.2021.9385.